Showing results (171-180 of 178) with videos related to

Sort By:
Pageof 18
You have reached the last page of results.This site can display upto 178 results.
Journal for Immunotherapy of Cancer|June 30, 2026
Metabolic inhibition of glutamate-cysteine ligase increases dendritic cell-mediated antitumor immunity in melanomaSophie Marie Dieckmann, Christoph H Tripp, Helen Strandt, et al.
Clinical Neuropathology|May 1, 2020
Quality assurance in neuropathology: Experiences from the round robin trials on IDH mutation and MGMT promoter methylation testing launched by the Quality Assurance Initiative Pathology (QuIP) in 2018 and 2019Markus J Riemenschneider, Josephine Fischer, Maja Grassow-Narlik, et al.
Cells|July 29, 2023
Scaffold-Based (Matrigel™) 3D Culture Technique of Glioblastoma Recovers a Patient-like Immunosuppressive PhenotypeFrank K Braun, Tanja Rothhammer-Hampl, Julia Lorenz, et al.
Molecular Psychiatry|June 22, 2022
Induced neural progenitor cells and iPS-neurons from major depressive disorder patients show altered bioenergetics and electrophysiological propertiesJulian Triebelhorn, Iseline Cardon, Kerstin Kuffner, et al.
Clinical Neuropathology|March 31, 2023
Update on quality assurance in neuropathology: Summary of the round robin trials on TERT promoter mutation, H3-3A mutation, 1p/19q codeletion, and KIAA1549::BRAF fusion testing in Germany in 2020 and 2021Sandra Pohl, Lora Dimitrova, Maja Grassow-Narlik, et al.
International Journal of Molecular Sciences|October 14, 2022
Metabolic Heterogeneity of Brain Tumor Cells of Proneural and Mesenchymal OriginCorinna Seliger, Anne-Louise Meyer, Verena Leidgens, et al.
Acta Neuropathologica Communications|September 11, 2023
Translocator protein (18kDA) (TSPO) marks mesenchymal glioblastoma cell populations characterized by elevated numbers of tumor-associated macrophagesLorraine Weidner, Julia Lorenz, Stefanie Quach, et al.
Brain Pathology (Zurich, Switzerland)|July 16, 2026
Interlaboratory performance testing on EPIC v2.0 CNS tumor profiling demonstrates high reproducibility of tumor classification but reveals the need for harmonized copy number variation reportingKatrin Mauch-Mücke, Christin Siewert, Lora Dimitrova, et al.
Pageof 18